-
Nobel winner Mukwege warns of predatory US deal for DR Congo
-
UK economy resilient as Mideast war, political risks loom
-
Russia pummels Kyiv, killing three and denting peace hopes
-
Subdued Trump left waiting for 'big hug' from Xi
-
Slot has 'every reason to believe' he will remain as Liverpool boss
-
British PM battles to stay in power amid rebellion
-
Ex-Philippine drug war enforcer flees Senate refuge
-
U2 surprise fans in Mexico City to shoot music video
-
Asia stocks uneven as investors assess high-stakes Trump-Xi talks, AI rally
-
Burberry returns to full-year profit on turnaround plan
-
Spiky, polarising, rarely dull: ups and downs of rugby's Eddie Jones
-
Denmark, Australia in the spotlight in Eurovision second semi
-
Heavy Russian strikes on Kyiv kill one, wound 31
-
Xi warns Trump on Taiwan at Beijing summit
-
Iran war and oil dominate BRICS meet in India
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
Kohli senses end after roaring back to form with IPL century
-
India bars sugar exports until September
-
Madonna, Shakira, BTS to headline first World Cup final half-time show
-
Japan takes 'half step' toward fixing slow retrial system
-
Honda posts operating loss, first since 1957
-
Madonna, Shakira, BTS to headline World Cup final half-time show
-
A quarter of World Cup games risk searing heat: scientists
-
Six hantavirus cruise passengers head to Australia
-
Suspect detained in Philippine senate gunfire: police
-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
NAV Fund Services (Ireland) Ltd. Expands European Fund Servicing Offering to Support UCITS Funds
-
AVI Urges the Dismissal of Two Directors at Wacom
-
PLAS-LABS Simplifies Scientific Validation With Automated Citation Tracking Powered by Bioz
-
Battery X Metals Achieves Milestone with Delivery of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Machine Featuring Design Enhancements, Advancing Strategic Commercialization Initiatives
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 14
-
Akkodis Recognized in HFS Horizons 2026 Report for Enterprise Ready Agentic AI Services
-
Lexus Of Oakville Recognized for Redefining the Luxury Dealership Experience With 2026 Consumer Choice Award
-
US renews offer of $100 mn to Cuba if it cooperates
-
City still 'alive' but need Arsenal slip: Guardiola
-
Man City ease past Palace to keep pressure on Arsenal
Trump announces drug prices cut with swipe at Europe
US President Donald Trump said Monday he would slash drug prices so that they match costs abroad, accusing the "brutal" European Union in particular of forcing pharmaceutical firms to lower prices on its turf.
Trump claimed as he signed the executive order at the White House that drug prices should fall by at least 59 percent -- and in some cases as high as 80 or 90 percent.
Under the plan, Trump aims to institute a "Most Favored Nation" policy that pins the cost of drugs sold in the United States to the lowest price paid by other countries for the same drug.
"Whoever is paying the lowest price, that's the price that we're going to get," Trump said.
The US president's plan will count mainly on the goodwill of pharmaceutical companies to negotiate their prices and could face legal challenges, as did a similar proposal Trump pushed during his first term.
Trump said American consumers had been treated like "suckers" and cited in particular the costs of the obesity-reducing drug Ozempic, which he said were vastly higher in Europe.
He blasted the European Union nation in particular over drug prices, alleging that the 27-nation bloc forced pharmaceutical firms to lower their costs on their territory.
"It was really the countries that forced Big Pharma to do things that, frankly, I'm not sure they really felt comfortable doing, but they've gotten away with it," Trump said.
"The European Union has been brutal, brutal. And the drug companies actually told me stories it was just brutal, how they forced them."
- 'Powerful lobby' -
Trump said he would also order an investigation into countries that "extort" drug companies by "blocking their products" unless they accepted low prices.
But Trump added that he was also "doing this against the most powerful lobby in the world -- the drug and pharmaceutical lobby."
Health Secretary Robert Kennedy Jr, who has caused controversy for his skepticism over vaccinations, praised the plan.
"There has never been a president more willing to stand up to the oligarchs than Donald Trump," Kennedy said as he stood next to the billionaire property developer.
Trump had trailed the announcement of the 59 percent cut earlier on Monday.
"DRUG PRICES TO BE CUT BY 59%, PLUS! Gasoline, Energy, Groceries, and all other costs, DOWN. NO INFLATION!!!" Trump posted on his Truth Social platform.
The reduction in prescription drug costs in the United States would, he added in his post, be counterbalanced by higher costs in other countries.
"Most favored nation" status is a World Trade Organization rule that aims to prevent discrimination between a country and its trading partners, levelling the playing field for international trade.
This is not the first time that Trump has attempted to lower US drug prices.
During his first 2017-2021 term in office, he announced a similar proposal to cut US drug prices but his plans failed in the face of strong opposition from the pharmaceutical industry.
Last month, the US president signed an executive order aiming to lower crippling drug prices by giving states more leeway to bargain-hunt abroad and improving the process for price negotiations.
T.Wright--AT